Form D · Other Health Care
Singular Bio, Inc.
San Francisco, CA · CIK 0001768097
Offering snapshot reported Feb 15, 2019 · SEC filing
- Reported sold
- $6.58M Offering amount: $7.98M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jan 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2019 | Initial | $6,575,395 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $400K
- Finders' fees
- $0
- Form D file number
- 021-333003
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Raymond James & Associates, Inc. | 705 | Raymond James & Associates, Inc. · CRD 705 |
Source: Form D, filed Feb 15, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eli Casdin | Director |
| Jones Hywel | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
455 Mission Bay Blvd. South, Suite 145
San Francisco, CA, 94158
San Francisco, CA, 94158